Amalgent is a fixed-dose combination therapeutics company developing alternatives to traditional opioid pain medications. The Company is developing combination products the provide effective analgesia at dramatically reduced doses. By reducing the dose, Amalgent's products minimize side effects like respiratory depression, confusion, constipation and addiction.
View Top Employees from Amalgent Therapeutics, Inc.Website | http://www.amalgent.com |
Employees | 2 (1 on RocketReach) |
Founded | 2020 |
Industry | Pharmaceutical Manufacturing |
Looking for a particular Amalgent Therapeutics, Inc. employee's phone or email?
Malcolm Meyn is the Co-Founder and Chief Scientific Officer of Amalgent Therapeutics, Inc..
1 people are employed at Amalgent Therapeutics, Inc..
Amalgent Therapeutics, Inc. is based in Greenville, North Carolina.